JND3229

TargetMol
Product Code: TAR-T15615
Supplier: TargetMol
CodeSizePrice
TAR-T15615-1mg1mg£173.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15615-5mg5mg£332.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15615-1mL1 mL * 10 mM (in DMSO)£426.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15615-10mg10mg£464.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15615-25mg25mg£723.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T15615-50mg50mg£978.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
JND3229 is a highly potent and fourth-generation EGFRC797S reversible inhibitor (IC50: 5.8 nM). It also effectively suppressed EGFRL858R/T790M and EGFRWT (IC50: 30.5 and 6.8 nM).
CAS:
2260886-64-2
Formula:
C33H41ClN8O2
Molecular Weight:
617.2
Pathway:
Angiogenesis|JAK/STAT signaling|Tyrosine Kinase/Adaptors
Purity:
0.98
SMILES:
CCC(=O)N[C@H]1CC[C@@H](CC1)N1C(=O)N(Cc2cnc(Nc3ccc(N4CCN(C)CC4)c(C)c3)nc12)c1ccccc1Cl
Target:
EGFR

References

Lu X, et al. Discovery of JND3229 as a New EGFRC797S Mutant Inhibitor with In Vivo Monodrug Efficacy. ACS Med Chem Lett. 2018 Oct 8;9(11):1123-1127.